This is the authors' abstract. We don't add key points for this paper.
We evaluated the associations between the in vitro activities of ethambutol and rifampin and clinical outcomes of Mycobacterium avium complex (MAC) pulmonary disease (PD). Among 158 patients with MAC-PD, there was no relationship between high MICs for ethambutol and/or rifampin and treatment failure for MAC-PD.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Moon et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: